180 related articles for article (PubMed ID: 18287049)
41. Phosphorylation at Thr-290 regulates Tpl2 binding to NF-kappaB1/p105 and Tpl2 activation and degradation by lipopolysaccharide.
Cho J; Tsichlis PN
Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2350-5. PubMed ID: 15699325
[TBL] [Abstract][Full Text] [Related]
42. Advancement in TPL2-regulated innate immune response.
Yan MH; Hao JH; Zhang XG; Shen CC; Zhang DJ; Zhang KS; Zheng HX; Liu XT
Immunobiology; 2019 May; 224(3):383-387. PubMed ID: 30853309
[TBL] [Abstract][Full Text] [Related]
43. A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway.
Tundup S; Srivastava L; Norberg T; Watford W; Harn D
PLoS One; 2015; 10(9):e0137495. PubMed ID: 26340260
[TBL] [Abstract][Full Text] [Related]
44. Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis.
Roulis M; Nikolaou C; Kotsaki E; Kaffe E; Karagianni N; Koliaraki V; Salpea K; Ragoussis J; Aidinis V; Martini E; Becker C; Herschman HR; Vetrano S; Danese S; Kollias G
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):E4658-67. PubMed ID: 25316791
[TBL] [Abstract][Full Text] [Related]
45. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.
Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS
Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of tumor progression locus 2 protein kinase decreases lipopolysaccharide-induced tumor necrosis factor alpha production due to the inhibition of the tip-associated protein induction in RAW264.7 cells.
Hirata K; Miyashiro M; Ogawa H; Taki H; Tobe K; Sugita T
Biol Pharm Bull; 2010; 33(7):1233-7. PubMed ID: 20606319
[TBL] [Abstract][Full Text] [Related]
47. TPL2 kinase is a suppressor of lung carcinogenesis.
Gkirtzimanaki K; Gkouskou KK; Oleksiewicz U; Nikolaidis G; Vyrla D; Liontos M; Pelekanou V; Kanellis DC; Evangelou K; Stathopoulos EN; Field JK; Tsichlis PN; Gorgoulis V; Liloglou T; Eliopoulos AG
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1470-9. PubMed ID: 23533274
[TBL] [Abstract][Full Text] [Related]
48. Tumor progression locus 2 differentially regulates IFNγ and IL-17 production by effector CD4+ T cells in a T cell transfer model of colitis.
Acuff NV; Li X; Kirkland R; Nagy T; Watford WT
PLoS One; 2015; 10(3):e0119885. PubMed ID: 25781948
[TBL] [Abstract][Full Text] [Related]
49. Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.
Keir ME; Latchman YE; Freeman GJ; Sharpe AH
J Immunol; 2005 Dec; 175(11):7372-9. PubMed ID: 16301644
[TBL] [Abstract][Full Text] [Related]
50. Toll-Like Receptor 2-Tpl2-Dependent ERK Signaling Drives Inverse Interleukin 12 Regulation in Dendritic Cells and Macrophages.
Groft SG; Nagy N; Boom WH; Harding CV
Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077627
[TBL] [Abstract][Full Text] [Related]
51. CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling.
Graham DB; Bell MP; Huntoon CJ; Griffin MD; Tai X; Singer A; McKean DJ
J Immunol; 2006 Nov; 177(9):6098-107. PubMed ID: 17056536
[TBL] [Abstract][Full Text] [Related]
52. Role of CTLA-4 in the activation of single- and double-positive thymocytes.
Kwon H; Jun HS; Khil LY; Yoon JW
J Immunol; 2004 Dec; 173(11):6645-53. PubMed ID: 15557155
[TBL] [Abstract][Full Text] [Related]
53. The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.
Berthou F; Ceppo F; Dumas K; Massa F; Vergoni B; Alemany S; Cormont M; Tanti JF
Mol Endocrinol; 2015 Jul; 29(7):1025-36. PubMed ID: 26020725
[TBL] [Abstract][Full Text] [Related]
54. Cystatin cures visceral leishmaniasis by NF-κB-mediated proinflammatory response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway.
Kar S; Ukil A; Das PK
Eur J Immunol; 2011 Jan; 41(1):116-27. PubMed ID: 21182083
[TBL] [Abstract][Full Text] [Related]
55. Contributions of the T cell receptor-associated CD3gamma-ITAM to thymocyte selection.
Haks MC; Pépin E; van den Brakel JH; Smeele SA; Belkowski SM; Kessels HW; Krimpenfort P; Kruisbeek AM
J Exp Med; 2002 Jul; 196(1):1-13. PubMed ID: 12093866
[TBL] [Abstract][Full Text] [Related]
56. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells.
Richardson ET; Shukla S; Sweet DR; Wearsch PA; Tsichlis PN; Boom WH; Harding CV
Infect Immun; 2015 Jun; 83(6):2242-54. PubMed ID: 25776754
[TBL] [Abstract][Full Text] [Related]
57. Disruption of Mekk2 in mice reveals an unexpected role for MEKK2 in modulating T-cell receptor signal transduction.
Guo Z; Clydesdale G; Cheng J; Kim K; Gan L; McConkey DJ; Ullrich SE; Zhuang Y; Su B
Mol Cell Biol; 2002 Aug; 22(16):5761-8. PubMed ID: 12138187
[TBL] [Abstract][Full Text] [Related]
58. Implication of the Tpl2 kinase in inflammatory changes and insulin resistance induced by the interaction between adipocytes and macrophages.
Ceppo F; Berthou F; Jager J; Dumas K; Cormont M; Tanti JF
Endocrinology; 2014 Mar; 155(3):951-64. PubMed ID: 24424060
[TBL] [Abstract][Full Text] [Related]
59. TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway.
Dumitru CD; Ceci JD; Tsatsanis C; Kontoyiannis D; Stamatakis K; Lin JH; Patriotis C; Jenkins NA; Copeland NG; Kollias G; Tsichlis PN
Cell; 2000 Dec; 103(7):1071-83. PubMed ID: 11163183
[TBL] [Abstract][Full Text] [Related]
60. B-Raf-mediated signaling pathway regulates T cell development.
Tsukamoto H; Irie A; Senju S; Hatzopoulos AK; Wojnowski L; Nishimura Y
Eur J Immunol; 2008 Feb; 38(2):518-27. PubMed ID: 18228248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
